INM – inmed pharmaceuticals inc. - common shares (US:NASDAQ)

News

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901 [Yahoo! Finance]
InMed Pharmaceuticals Reports Full Year Fiscal 2025 Financial Results and Provides Business Update [Yahoo! Finance]
InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M [Seeking Alpha]
InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com